EXPLORINEER
en

KR — ZDNet Korea

Arizona Veterans Research and Education Foundation and Young Blood Institute Announce CRADA for Alzheimer's Pilot Study, Supporting Phoenix VA Health Care System

Policy2 min read

Ambarri Healthcare and the Young Blood Institute (YBI) announced a research deal with the Phoenix VA Health Care System and the Arizona Veterans Research and Education Foundation. They will test a blood-cleaning treatment in military veterans who have early Alzheimer's disease.

What happened

On November 19, 2026, four groups announced a cooperative research and development agreement (CRADA). The groups are AmβARI Healthcare, the Phoenix VA Health Care System, the Arizona Veterans Research and Education Foundation, and the Young Blood Institute. Together they will run a small pilot study. It tests an improved form of therapeutic plasma exchange (TPE). TPE is a treatment that removes part of the blood's plasma, the liquid part of blood, and replaces it. The study will look at veterans with mild cognitive impairment (MCI) or early-stage Alzheimer's disease.

Key numbers and facts

  • The study is called the AMBAR VA study (VA protocol 1859907).
  • Up to 56 veterans will join. It is a randomized controlled trial, meaning people are assigned to groups by chance and compared.
  • The main measure is the change in amyloid in the brain. Amyloid is a sticky protein linked to Alzheimer's. It is measured with brain PET-CT scans that use a tracer called NAV-4694.
  • In earlier AMBAR trials, 61% of patients with early to moderate Alzheimer's had slower or stopped disease progression. Memory improved in 11% to 15% of patients.
  • The original AMBAR trial included 498 patients. The Ace Alzheimer Center Barcelona has done over 2,100 standard TPE treatments.

Background

Alzheimer's disease slowly destroys memory and thinking skills. Researchers are testing many ways to slow it. TPE is one of them. The idea is that removing harmful proteins from the blood may also reduce them in the brain. The Young Blood Institute is a nonprofit clinical research group in the United States. Ambarri Healthcare is its exclusive partner and pays for the research. The Phoenix VA Health Care System serves about 130,000 veterans in Arizona.

Why it matters

Alzheimer's is a serious disease, and few treatments can slow it down. If this pilot study shows good results, doctors could offer a new option to veterans. The study also tests whether the amyloid idea of Alzheimer's is correct. The study runs under federal rules and is overseen by the VA's Institutional Review Board (IRB), a group that checks that research is safe and ethical.

What to watch

  • Whether the 56 veterans are enrolled as planned.
  • Whether the brain scans show less amyloid in the treatment group.
  • Whether the study shows how TPE removes amyloid from the brain.
  • Whether the results are strong enough for larger studies.

Glossary

TPE
Therapeutic plasma exchange: a treatment that removes and replaces part of the blood's plasma (the liquid part of blood).
CRADA
Cooperative Research and Development Agreement: a formal deal that lets government and outside groups work on research together.
Young Blood Institute (YBI)
A nonprofit clinical research group that supports biomedical research.
Amyloid
A sticky protein that builds up in the brain and is linked to Alzheimer's disease.
NAV-4694
A tracer, a special chemical used with PET scans to show amyloid in the brain.

Ad

Add 150 words. Learn 10 a day.

Dicter word books send only the words you learn to your review notes.

PolicyArs Technica

Review: Godzilla Minus Zero joins the list of truly stellar sequels

Critic review says Godzilla Minus Zero, director Takashi Yamazaki's sequel to Godzilla Minus One, ranks among the rare sequels that match or surpass their predecessors. The article notes the film combines human drama, strong special effects, and a giant-monster battle, and it follows Minus One's postwar setting and themes of guilt and redemption.

PolicyThe Verge

Amazon is complaining about NYC Council on shipping labels, too

Amazon is now printing messages on shipping labels saying the New York City Council could add up to $5 per order, following similar notices in its app and website. The company is fighting the Delivery Protection Act, which would effectively ban the third-party delivery arrangements it uses and require last-mile warehouse operators to be licensed and directly employ their workers. Amazon says the bill would mean slower, more expensive delivery and has threatened to move warehouses out of the city, while labor unions, Council Speaker Julie Menin, and Mayor Zohran Mamdani accused the company of greed and intimidation.

PolicyZDNet Korea

2026 APEC CEO Summit Closes Successfully in Shenzhen

The 2026 APEC CEO Summit concluded on November 18 at the Shenzhen Qianhai International Convention Center. Hosted by the China Council for the Promotion of International Trade (CCPIT) as a side event of the 33rd APEC Economic Leaders' Meeting, the summit drew more than 2,000 political and business leaders, including representatives from all 21 APEC members and 13 non-member economies. The event also saw the presentation of the Shenzhen Initiative, the first time in its 30-year history that the summit's outcomes were released in initiative form.

PolicyThe Verge

The UN fails to agree on rules regulating ‘killer robots’

UN diplomats meeting in Geneva failed to reach agreement on rules for autonomous weapons, known as "killer robots," and instead agreed to "start discussing options." The International Committee of the Red Cross and the UN secretary-general had called for legally binding rules within a year, but countries were given two years to propose regulations, with some possibly remaining optional. According to NPR, Russia, Israel, and the US were the primary obstacles, with Russia delaying proceedings over the agenda and the US proposing a five-year window to discuss nonbinding guidelines.